How Imaging Glutamate, γ‐Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal

Abstract

Neuroimaging studies have dramatically advanced our understanding of the neurochemical basis of alcohol dependence, a major public health issue. In this paper we review the research generated from neurochemical-specific imaging modalities including magnetic resonance spectrometry (MRS), positron emission tomography (PET), and single photon emission computed tomography (SPECT) in studies of alcohol dependence and withdrawal. We focus on studies interrogating γ-aminobutryic acid (GABA), glutamate, and dopamine, as these are prominent neurotransmitter systems implicated in alcohol dependence. Highlighted findings include diminished dopaminergic functioning and modulation of the GABA system by tobacco smoking during alcohol withdrawal. Then, we consider how these findings impact the clinical treatment of alcohol dependence and discuss directions for future experiments to address existing gaps in the literature, e.g., sex differences and smoking comorbidity. These and other considerations provide opportunities to build upon the current neurochemistry imaging literature of alcohol dependence and withdrawal, which may usher in improved therapeutic and relapse prevention strategies.

Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

“…For example, the increasing availability of PET ligands suitable for human testing will allow interrogation of drug-induced changes in receptor availability that could confirm preclinical observations of reduced presynaptic GPCR expression following repeated drug exposure without relying on the use of postmortem brain samples. In addition, methods such as magnetic resonance spectroscopy that can be used to study neurotransmitter dynamics in humans create the opportunity to assess the impact of long-term drug abuse on glutamate transmission and to test the ability of clinical drug candidates that target presynaptic GPCRs to modulate glutamate transmission in the addicted brain (Hillmer et al, 2015; Volkow et al, 2015). Ultimately, variables such as the abused drug(s) and history of drug taking will likely play a role in the efficacy of pharmacological interventions targeting presynaptic GPCRs.…”

News and views on in-vivo imaging of neurotransmission using PET and MRI

“…Finally, neurotransmitter releasing drugs can also be inhaled, such as in the case of nicotine through cigarette smoking 62–64 . In this context, 2-[ 18 F]FA has been applied to reveal changes in α4β2 nACh receptor, for example by cigarette smoking showing that that smoking of one cigarette produced almost 90 % receptor occupancy 65 .…”

Gamma-Hydroxybutyrate (GHB) Content in Hair Samples Correlates Negatively with Age in Succinic Semialdehyde Dehydrogenase Deficiency

“…While the neurochemistry of GABA is well known (Hillmer et al 2015), the pharmacology of GHB remains unclear. GHB, an endogenous intermediate in the central nervous system present at~1% of parent GABA, is neuromodulatory in its effects on dopamine release and uptake (Maitre et al 2016).…”